Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Daratumumab-based therapy in patients with heavily-pretreated AL amyloidosis.

Literature DB >> 30267007

Daratumumab-based therapy in patients with heavily-pretreated AL amyloidosis.

Jithma P Abeykoon^1,2, Saurabh Zanwar^1,2, Angela Dispenzieri^1,2, Morie A Gertz^1,2, Nelson Leung^1,2,3, Taxiarchis Kourelis^1,2, Wilson Gonsalves^1,2, Eli Muchtar^1,2, David Dingli^1,2, Martha Q Lacy^1,2, Suzanne R Hayman^1,2, Francis Buadi^1,2, Rahma Warsame^1,2, Robert A Kyle^1,2, Vincent Rajkumar^1,2, Shaji Kumar^1,2, Prashant Kapoor^4,5.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2018 PMID： 30267007 DOI： 10.1038/s41375-018-0262-2

Source DB: PubMed Journal: Leukemia ISSN： 0887-6924 Impact factor: 11.528

Keyword Cloud
Cited

× No keyword cloud information.

24 in total

Review 1. New developments in diagnosis, risk assessment and management in systemic amyloidosis.

Authors: Iuliana Vaxman; Angela Dispenzieri; Eli Muchtar; Morie Gertz
Journal: Blood Rev Date: 2019-11-02 Impact factor: 8.250

2. Pilot Study of Bortezomib and Dexamethasone Pre- and Post-Risk-Adapted Autologous Stem Cell Transplantation in AL Amyloidosis.

Authors: Heather Landau; Oscar Lahoud; Sean Devlin; Nikoletta Lendvai; David J Chung; Ahmet Dogan; C Ola Landgren; Sergio Giralt; Hani Hassoun
Journal: Biol Blood Marrow Transplant Date: 2019-08-22 Impact factor: 5.742

3. Organ responses with daratumumab therapy in previously treated AL amyloidosis.

Authors: Alfred Chung; Gregory P Kaufman; Surbhi Sidana; Erik Eckhert; Stanley L Schrier; Richard A Lafayette; Sally Arai; Ronald M Witteles; Michaela Liedtke
Journal: Blood Adv Date: 2020-02-11

4. Daratumumab in light chain deposition disease: rapid and profound hematologic response preserves kidney function.

Authors: Paolo Milani; Marco Basset; Paola Curci; Andrea Foli; Rita Rizzi; Mario Nuvolone; Raffaella Guido; Loreto Gesualdo; Giorgina Specchia; Giampaolo Merlini; Giovanni Palladini
Journal: Blood Adv Date: 2020-04-14

Review 5. Systemic amyloidosis: moving into the spotlight.

Authors: Oliver C Cohen; Ashutosh D Wechalekar
Journal: Leukemia Date: 2020-04-09 Impact factor: 11.528

Review 6. Efficacy and safety of intravenous daratumumab-based treatments for AL amyloidosis: a systematic review and meta-analysis.

Authors: Chunyan Sun; Xiaohong Wang; Renyi Zhang; Lingjie Xu; Bin Wang; Jian Li
Journal: Cancer Cell Int Date: 2022-07-04 Impact factor: 6.429

7. Safety, tolerability, and response rates of daratumumab in relapsed AL amyloidosis: results of a phase 2 study.

Authors: Vaishali Sanchorawala; Shayna Sarosiek; Amanda Schulman; Meredith Mistark; Mary Ellen Migre; Ramon Cruz; J Mark Sloan; Dina Brauneis; Anthony C Shelton
Journal: Blood Date: 2020-04-30 Impact factor: 22.113

8. Characterization and prognostic implication of delayed complete response in AL amyloidosis.

Authors: Eli Muchtar; Morie A Gertz; Shaji K Kumar; Martha Q Lacy; Nelson Leung; Francis K Buadi; David Dingli; Suzanne R Hayman; Ronald S Go; Prashant Kapoor; Wilson Gonsalves; Taxiarchis V Kourelis; Rahma Warsame; Yi Lisa Hwa; Amie Fonder; Miriam Hobbs; Stephen Russell; John A Lust; Mustaqueem Siddiqui; S Vincent Rajkumar; Robert A Kyle; Angela Dispenzieri
Journal: Eur J Haematol Date: 2020-12-04 Impact factor: 2.997

Review 9. Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021.

Authors: M Hasib Sidiqi; Morie A Gertz
Journal: Blood Cancer J Date: 2021-05-15 Impact factor: 11.037

Review 10. Comprehensive Review of AL amyloidosis: some practical recommendations.

Authors: Rama Al Hamed; Abdul Hamid Bazarbachi; Ali Bazarbachi; Florent Malard; Jean-Luc Harousseau; Mohamad Mohty
Journal: Blood Cancer J Date: 2021-05-18 Impact factor: 11.037